Clinical Trial Update: Efficacy and Safety Study of PG201 Tablet in Patients With Osteoarthritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of PG201 Tablet in osteoarthritis of the knee has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• PG201 Tablet (PG201)

Snippet

Sponsor: Helixmith Co., Ltd. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: WITHDRAWN